Zanubrutinib Versus Bendamustine and Rituximab in Patients With Treatment-Naïve Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: Median 5-Year Follow-Up of SEQUOIA The rates of complete ...
Bionano Symposium 2026 continues with Day 2: New Frontiers in Oncology and Bioprocessing Applications on February 24, 2026, from 7:00-10:00 AM PT. Attendees may also explore scientific posters ...
Devonian Health Group Inc. ("Devonian" or the Company) today announced that a proprietary Thykaminetm fingerprint has been formally filed in two recent patent applications and is now a core component ...
Several potentially practice-changing phase 3 trials alongside promising results in emerging strategies in chronic lymphocytic leukemia (CLL) presented at the 2025 American Society of Hematology ...
National security, unlocked. Each Thursday, host Mary Louise Kelly and a team of NPR correspondents discuss the biggest national security news of the week. With decades of reporting from battlefields ...
Rock the Country festival: Artists dropping out amid Kid Rock controversy Underground homeless camp found under Stockton bridge The typical American worker has $955 saved for retirement Two Brits try ...
Only one in ten treatments for back pain actually work, a study suggests. The experts found that just one treatment for acute low back pain and five treatments for chronic – or long-term – back pain ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results